Amy C. Moore, Former Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, shared a post on LinkedIn:
“I am excited to announce that I am joining Summit Therapeutics as Director, Patient Engagement and Advocacy. I look forward to continuing to work within the lung cancer community and beyond as the team develops ivonescimab.”